扶桑薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/04/07 | 1,972 | 1,976 | 1,941 | 1,964 | +6 | +0.3% | 6,900 |
2023/04/06 | 1,968 | 1,989 | 1,958 | 1,958 | -15 | -0.8% | 6,100 |
2023/04/05 | 1,984 | 1,994 | 1,968 | 1,973 | -39 | -1.9% | 6,700 |
2023/04/04 | 2,023 | 2,032 | 2,001 | 2,012 | -8 | -0.4% | 11,500 |
2023/04/03 | 2,001 | 2,025 | 2,001 | 2,020 | +24 | +1.2% | 4,600 |
2023/03/31 | 1,993 | 2,011 | 1,988 | 1,996 | -9 | -0.4% | 6,600 |
2023/03/30 | 2,026 | 2,029 | 2,005 | 2,005 | -61 | -3% | 8,800 |
2023/03/29 | 2,023 | 2,066 | 2,003 | 2,066 | +59 | +2.9% | 11,600 |
2023/03/28 | 2,001 | 2,010 | 1,985 | 2,007 | -5 | -0.2% | 2,900 |
2023/03/27 | 1,999 | 2,013 | 1,993 | 2,012 | +37 | +1.9% | 5,100 |
2023/03/24 | 1,996 | 1,996 | 1,970 | 1,975 | -5 | -0.3% | 5,800 |
2023/03/23 | 1,974 | 1,985 | 1,963 | 1,980 | -5 | -0.3% | 4,200 |
2023/03/22 | 1,964 | 1,988 | 1,964 | 1,985 | +22 | +1.1% | 5,500 |
2023/03/20 | 2,010 | 2,010 | 1,963 | 1,963 | -33 | -1.7% | 8,600 |
2023/03/17 | 1,991 | 2,010 | 1,986 | 1,996 | +30 | +1.5% | 5,900 |
2023/03/16 | 1,966 | 1,971 | 1,952 | 1,966 | -13 | -0.7% | 5,600 |
2023/03/15 | 1,984 | 1,990 | 1,973 | 1,979 | +19 | +1% | 4,000 |
2023/03/14 | 2,000 | 2,000 | 1,950 | 1,960 | -40 | -2% | 7,500 |
2023/03/13 | 1,997 | 2,000 | 1,971 | 2,000 | -1 | ±0% | 6,400 |
2023/03/10 | 2,021 | 2,029 | 2,001 | 2,001 | -47 | -2.3% | 17,700 |
2023/03/09 | 2,051 | 2,065 | 2,036 | 2,048 | -3 | -0.1% | 5,500 |
2023/03/08 | 2,015 | 2,059 | 2,015 | 2,051 | +17 | +0.8% | 5,500 |
2023/03/07 | 2,007 | 2,042 | 2,007 | 2,034 | +29 | +1.4% | 7,100 |
2023/03/06 | 2,000 | 2,011 | 2,000 | 2,005 | -3 | -0.1% | 4,100 |
2023/03/03 | 1,980 | 2,008 | 1,980 | 2,008 | +37 | +1.9% | 7,200 |
2023/03/02 | 2,001 | 2,002 | 1,971 | 1,971 | -19 | -1% | 5,100 |
2023/03/01 | 1,978 | 1,998 | 1,978 | 1,990 | +9 | +0.5% | 3,100 |
2023/02/28 | 1,996 | 2,003 | 1,981 | 1,981 | -15 | -0.8% | 6,300 |
2023/02/27 | 1,996 | 1,996 | 1,981 | 1,996 | +19 | +1% | 4,000 |
2023/02/24 | 1,958 | 1,979 | 1,958 | 1,977 | +12 | +0.6% | 3,000 |
2023/02/22 | 1,967 | 1,971 | 1,955 | 1,965 | -6 | -0.3% | 2,600 |
2023/02/21 | 1,952 | 1,976 | 1,952 | 1,971 | +17 | +0.9% | 2,700 |
2023/02/20 | 1,970 | 1,985 | 1,954 | 1,954 | -16 | -0.8% | 9,200 |
2023/02/17 | 1,968 | 1,974 | 1,951 | 1,970 | +1 | +0.1% | 3,000 |
2023/02/16 | 1,951 | 1,969 | 1,945 | 1,969 | +22 | +1.1% | 4,600 |
2023/02/15 | 1,982 | 1,982 | 1,947 | 1,947 | -18 | -0.9% | 3,100 |
2023/02/14 | 1,958 | 1,970 | 1,952 | 1,965 | +17 | +0.9% | 4,200 |
2023/02/13 | 1,963 | 1,963 | 1,936 | 1,948 | -18 | -0.9% | 2,700 |
2023/02/10 | 1,915 | 1,988 | 1,915 | 1,966 | +36 | +1.9% | 10,800 |
2023/02/09 | 1,921 | 1,930 | 1,921 | 1,930 | +3 | +0.2% | 600 |
2023/02/08 | 1,921 | 1,931 | 1,921 | 1,927 | ±0 | ±0% | 1,000 |
2023/02/07 | 1,924 | 1,940 | 1,924 | 1,927 | -10 | -0.5% | 1,200 |
2023/02/06 | 1,960 | 1,960 | 1,935 | 1,937 | +17 | +0.9% | 4,700 |
2023/02/03 | 1,923 | 1,928 | 1,913 | 1,920 | -16 | -0.8% | 2,900 |
2023/02/02 | 1,954 | 1,954 | 1,935 | 1,936 | -14 | -0.7% | 6,100 |
2023/02/01 | 1,954 | 1,955 | 1,943 | 1,950 | +15 | +0.8% | 2,000 |
2023/01/31 | 1,915 | 1,952 | 1,915 | 1,935 | +47 | +2.5% | 11,300 |
2023/01/30 | 1,943 | 1,964 | 1,888 | 1,888 | -70 | -3.6% | 15,700 |
2023/01/27 | 1,956 | 1,958 | 1,933 | 1,958 | +8 | +0.4% | 6,800 |
2023/01/26 | 1,952 | 1,956 | 1,937 | 1,950 | -10 | -0.5% | 4,200 |
401~
450
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「扶桑薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
ハートシード | 145,000円 | +154.1% | - | 0.00% | - | 7.10倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
市場注目の銘柄
チャート関連のコラム